Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase SignalingChen Liu, Huai‐Xiang Hao|Clinical Cancer Research|2020Cited by 161
Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFRHengyu Lu, Huai‐Xiang Hao|Oncotarget|2020Cited by 41